• Its lead product, Proxima, provides near real-time analysis of blood gases, electrolytes, and metabolites at the patient's bedside within critical care. (trinitydelta.org)
  • Dr Wolfgang Rencken, chief executive of Sphere Medical, said: "Based on clinical feedback, we have launched our next-generation Proxima, which is now even better placed to support rapid and frequent measurements of blood gases, electrolytes and metabolites without blood loss. (buildingbetterhealthcare.com)
  • Sphere Medical was formed in 2002and raised c £27m in various private financings to principally develop the Proxima blood analyser. (trinitydelta.org)
  • The bedside blood gas analyser (BGA) incorporates a new design and an extended analyte panel. (buildingbetterhealthcare.com)
  • This is possible since the Proxima sensor contains an array of proven biosensor technology on a silicon chip, each a miniaturised version of the electrochemical sensors used in a traditional blood gas analyser. (buildingbetterhealthcare.com)
  • As an ex-vivo analyser operating as a closed system, blood is drawn directly from the patient and over the Proxima sensor. (buildingbetterhealthcare.com)
  • Sphere Medical, a leading developer of innovative monitoring and diagnostic devices for the critical care setting, is pleased to announce that it has achieved CE mark for the Proxima system, a patient dedicated arterial blood gas analyser. (healthmanagement.org)
  • The ability to regularly monitor arterial blood glucose using Proxima will support closer clinical management for improved glycaemic control. (buildingbetterhealthcare.com)
  • Frequent measurement of arterial blood samples is an important component in the effective management. (healthmanagement.org)
  • Proxima 3 providing valuable clinical insights Sphere Medical launched the Proxima 3 blood gas diagnostic system in 2015. (trinitydelta.org)
  • The design of Proxima also reduces pre-analytical errors due to the delivery of a high-integrity blood sample direct to the sensor for immediate analysis with no mixing or anti-coagulant required. (buildingbetterhealthcare.com)
  • The ability to monitor blood gases and measure blood glucose frequently and easily, directly by the patient, can enable earlier interventions and closer patient management, which is vital in fast-changing critical situations. (buildingbetterhealthcare.com)
  • Following analysis, all blood is returned to the patient, meaning there is no blood loss and the risk of iatrogenic anaemia is reduced. (buildingbetterhealthcare.com)
  • Scalable and customized hematology workcells help move labs forward by streamlining workflow with first pass results accuracy Capitalising on the advanced technologies behind Beckman Coulter Diagnostics' DxH 800 and DxH Slidemaker Stainer cellular analysis systems, the company has released the new UniCel DxH connected Workcell solution for in. (healthmanagement.org)